TLDR Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.
The study found that the use of renin-angiotensin system-targeting antihypertensive agents or statins significantly reduced serum HER2 levels in women. Additionally, higher serum HER2 levels were associated with an increased prevalence of metabolic syndrome (MS), indicating that elevated HER2 could be an independent risk factor and a potential biomarker for MS in women.
May 2017 in “American Society of Health-System Pharmacists eBooks” 
295 citations
,
September 2006 in “Cell Cycle” The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.
1 citations
,
January 2010 in “Elsevier eBooks” Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.
1 citations
,
September 2020 in “Endocrinology, Diabetes & Metabolism Case Reports” The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.
7 citations
,
September 2023 in “Cancer Treatment Reviews” Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.
